HomeCompareETNB vs SPHD

ETNB vs SPHD: Dividend Comparison 2026

ETNB yields 13.48% · SPHD yields 4.30%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ETNB wins by $22.0K in total portfolio value
10 years
ETNB
ETNB
● Live price
13.48%
Share price
$14.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$48.5K
Annual income
$3,111.66
Full ETNB calculator →
SPHD
SPHD
● Live price
4.30%
Share price
$49.61
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$567.37
Full SPHD calculator →

Portfolio growth — ETNB vs SPHD

📍 ETNB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodETNBSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ETNB + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ETNB pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ETNB
Annual income on $10K today (after 15% tax)
$1,145.55/yr
After 10yr DRIP, annual income (after tax)
$2,644.91/yr
SPHD
Annual income on $10K today (after 15% tax)
$365.92/yr
After 10yr DRIP, annual income (after tax)
$482.26/yr
At 15% tax rate, ETNB beats the other by $2,162.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ETNB + SPHD for your $10,000?

ETNB: 50%SPHD: 50%
100% SPHD50/50100% ETNB
Portfolio after 10yr
$37.5K
Annual income
$1,839.51/yr
Blended yield
4.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ETNB right now

ETNB
Analyst Ratings
9
Buy
6
Hold
Consensus: Buy
Price Target
$17.17
+15.7% upside vs current
Range: $12.00 — $25.00
Altman Z
12.5
Piotroski
2/9
SPHD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ETNB buys
0
SPHD buys
0
No recent congressional trades found for ETNB or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricETNBSPHD
Forward yield13.48%4.30%
Annual dividend / share$2.00$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$48.5K$26.5K
Annual income after 10y$3,111.66$567.37
Total dividends collected$22.0K$5.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ETNB vs SPHD ($10,000, DRIP)

YearETNB PortfolioETNB Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$12,048$1,347.71$11,130$430.50+$918.00ETNB
2$14,409$1,517.46$12,357$447.82+$2.1KETNB
3$17,113$1,696.08$13,687$464.65+$3.4KETNB
4$20,194$1,882.68$15,126$480.98+$5.1KETNB
5$23,684$2,076.25$16,682$496.78+$7.0KETNB
6$27,617$2,275.75$18,362$512.03+$9.3KETNB
7$32,031$2,480.12$20,174$526.72+$11.9KETNB
8$36,961$2,688.28$22,127$540.84+$14.8KETNB
9$42,447$2,899.14$24,230$554.39+$18.2KETNB
10$48,530$3,111.66$26,493$567.37+$22.0KETNB

ETNB vs SPHD: Complete Analysis 2026

ETNBStock

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.

Full ETNB Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this ETNB vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ETNB vs SCHDETNB vs JEPIETNB vs OETNB vs KOETNB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.